Global Financial Private Client
ABBV icon

Global Financial Private Client’s AbbVie ABBV Stock Holding History

Global Financial Private Client’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.75M Buy
6,675
+657
+11% +$168K 0.48% 58
2026
Q2 		$1.51M Buy
6,018
+96
+2% +$20.7K 0.41% 71
2026
Q1 		$1.29M Buy
5,922
+653
+12% +$145K 0.42% 71
2025
Q4 		$1.2M Buy
5,269
+853
+19% +$194K 0.42% 71
2025
Q3 		$1.02M Buy
4,416
+138
+3% +$28.1K 0.36% 84
2025
Q2 		$794K Buy
4,278
+1,460
+52% +$271K 0.3% 94
2025
Q1 		$591K Buy
2,818
+67
+2% +$13K 0.23% 112
2024
Q4 		$489K Buy
2,751
+28
+1% +$5.15K 0.18% 134
2024
Q3 		$538K Buy
2,723
+196
+8% +$36.6K 0.21% 123
2024
Q2 		$434K Buy
2,527
+1
+0% +$166 0.18% 133
2024
Q1 		$457K Buy
2,526
+4
+0.2% +$689 0.2% 128
2023
Q4 		$391K Sell
2,522
-328
-12% -$47.8K 0.18% 133
2023
Q3 		$423K Buy
2,850
+2
+0.1% +$294 0.22% 107
2023
Q2 		$385K Sell
2,848
-1,175
-29% -$172K 0.19% 122
2023
Q1 		$645K Buy
4,023
+1
+0% +$153 0.33% 71
2022
Q4 		$650K Buy
4,022
+348
+9% +$53.4K 0.36% 68
2022
Q3 		$508K Buy
3,674
+260
+8% +$37.3K 0.29% 79
2022
Q2 		$525K Buy
3,414
+209
+7% +$31.9K 0.3% 76
2022
Q1 		$521K Buy
3,205
+793
+33% +$115K 0.25% 86
2021
Q4 		$327K Buy
2,412
+231
+11% +$27.3K 0.16% 117
2021
Q3 		$238K Buy
2,181
+2
+0.1% +$229 0.12% 132
2021
Q2 		$249K Buy
2,179
+1
+0% +$113 0.14% 120
2021
Q1 		$236K Sell
2,178
-17
-0.8% -$1.82K 0.17% 106
2020
Q4 		$235K Buy
2,195
+22
+1% +$2.11K 0.19% 94
2020
Q3 		$189K Sell
2,173
-396
-15% -$37.3K 0.16% 99
2020
Q2 		$255K Sell
2,569
-164
-6% -$14.4K 0.22% 94
2020
Q1 		$201K Hold
2,733
– – 0.21% 98
2019
Q4 		$242K Buy
+2,733
New +$227K 0.2% 101

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Global Financial Private Client's ABBV Position: Q3 2026 in Review

Global Financial Private Client increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $168K and bringing the position to 6,675 shares worth $1.75M. The position accounts for 0.48% of the portfolio, ranked #58.

Global Financial Private Client first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Global Financial Private Client held 6,675 shares of AbbVie worth $1.75M as of Q3 2026.
  • Global Financial Private Client bought 657 AbbVie shares in Q3 2026, an estimated $168K.
  • AbbVie made up 0.48% of Global Financial Private Client's portfolio in Q3 2026, its #58 holding.
  • Global Financial Private Client first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Global Financial Private Client's 13F filing for Q3 2026, filed 15 Oct 2026.